The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction

Although mesenchymal stem cells (MSC) have been shown to be safe in preclinical studies of cardiovascular disease, multiple meta-analyses have debated whether functional improvement is significant or not. The cardiac differentiation from MSC is achievable using cardiogenic factors, however, the high...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Cho, Dong Im, Kang, Wan Seok, Hong, Moon Hwa, Kang, Hye Jin, Kim, Mi Ra, Kim, Min Chul, Kim, Yong Sook, Ahn, Youngkeun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546480/
https://ncbi.nlm.nih.gov/pubmed/28498815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17471
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi